A lock ( Consumers can call or write to the institute with questions and can order publications over the phone or on the Web site. Bacterial Diseases. Diseases include food allergy, sinusitis, and genital herpes. However, this can only be accomplished with the cooperation of parents and health care providers who adhere to these recommendations. Paramyxoviridae: Nipah Virus and Hendra Virus. NIAID provides health information on allergic, infectious, and immunologic diseases. Enteric Diseases. Drug Development Research. Adherence to these clinical practice recommendations can help potentially reduce the number of cases of peanut allergy per year. MD Metabolon, Inc. will participate in the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, Immunophenotyping Assessment in a COVID-19 Cohort, or IMPACC, study (grant no: 5U19AI118602-04). Please enable JavaScript in your web browser; otherwise some parts of this site might not work properly. NIAID: International Involvement in HIV/AIDS Research: Clinical Trial Network Studies- ACTG, HVTN, IMPAACT, INSIGHT, MTN, Non-Clinical Trial Network Studies, Centers for AIDS Research (CFARs), Comprehensive International Program of Research on AIDS (CIPRA), International Databases to Evaluate AIDS (IeDEA), Male Circumcision, NIAID Collaborative International Research, U.S. Military HIV Research Program (USMHRP) Trials funded by NIAID, Other HIV/AIDS Vaccine Related Work, International AIDS Vaccine Initiative (IAVI), Partnership for AIDS Vaccine Evaluation (PAVE), Center for HIV/AIDS Vaccine Immunology (CHAVI), Global HIV Vaccine Enterprise (GHVE), President’s Emergency Plan for AIDS Research (PEPFAR). Vaccine Development: Vaccine Clinical Trials, Vaccine Discovery and Development/Clinical Research, The Failure of the STEP Trial. Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome. Inauguration of the President of the United States, National Institute of Allergy and Infectious Diseases (NIAID), U.S. Department of Health and Human Services. Fungal Diseases. 2020 May;31(4):418-420. doi: 10.1111/pai.13223. Based on these findings, the National Institutes of Allergy and Infectious Diseases sponsored an expert panel to create an addendum to the 2010 Food Allergy Guidelines that specifically focuses on peanut allergy prevention. ) or https:// means you’ve safely connected to the .gov website. NIAID: Programs in HIV/AIDS Therapeutics: Drug Discovery, Preclinical Drug Development, Clinical Research, Resources for Researchers, NIAID Funding Initiatives, Clinical Trials, Other NIH-Funded Clinical Trials Networks, Clinical Trials Guidelines. Immune Tollerance. Transplantation. Tropical Medicine and Parasitic Diseases. 2017 Mar 1;38(2):85-87. doi: 10.2500/aap.2017.38.4040. doi: 10.1111/pde.13093. Allergy Asthma Proc. Sexually-Transmitted Diseases. Arthropod-Borne Viral Encephalitis: Flaviviruses, Aphaviruses, Bunyaviruses. The NIH website offers health information for the public, scientists, researchers, medical professionals, patients, educators, 5601 Fishers Lane For children with mild-to-moderate eczema, peanut can be introduced at ∼6 months, without the need for specialist evaluation. Secure .gov websites use HTTPS In pursuit of this goal and its disease-specific scientific objectives, NIAID seeks to broaden its global impact by increasing scientific opportunities and collaborations involving scientists and institutions outside the United States. J Pediatr Nurs. Nevertheless, this volume is not an official U.S. Government publication.FeaturesIncludes detailed up-to-date overviews of specific research endeavors in microbiology and infectious diseases (other than HIV/AID), HIV/AIDS, allergy, immunology, and transplantation.ContentsForeword: Anthony S. Fauci, MD. Immune Adjuvants. Abrams EM, Brough HA, Keet C, Shaker MS, Venter C, Greenhawt M. Lancet Child Adolesc Health. The addendum recommends that children with severe eczema, egg allergy, or both have peanut introduced as early as 4-6 months of life, after assessment by a trained allergy specialist. This volume comprises documents of the United States Government and other research information that is in the public domain. Herpesviruses. J Allergy Clin Immunol. Copyright © 2020 Apple Inc. All rights reserved. Malaria. Defense against Biological Weapons (Biodefense): History of Biological Warfare, Anthrax, Variola major Virus (Smallpox), Yersinia pestis (Plague), Brucellosis, Coxiella burnetii-Q fever, Glanders, Melioidosis, Viral Hemorrhagic Fever: Filoviruses, Viral Hemorrhagic Fever: Bunyaviridae, Viral Hemorrhagic Fever: Arenaviruses, Viral Hemorrhagic Fever: Flaviviruses, Protein Toxin Weapons, Arthropod-Borne Viral Fever and Arthropathy, NIAID Research Agenda in Biodefense Antimicrobial Resistance and Healthcare-Acquired Infections.  |  HIV/AIDS Epidemiology. Consumers can call or write to the institute with questions and can order publications over the phone or on the Web site. Part II. Opportunistic Infections: Fungal Infections, Viral Infections, Parasitic Infections, Recent NIAID-Supported Clinical Studies in Opportunistic Infections. The addendum recommends that children with severe eczema, egg allergy, or both have peanut introduced as early as 4-6 months of life, after assessment by a trained allergy … Pediatr Dermatol. An agency of the U.S. Department of Health and Human Services, the NIH is the Federal focal point for health and medical research. Severe Acute Respiratory Syndrome (SARS). Bethesda, Tick-Borne Bacterial, Rickettsial, Spirochetal, and Protozoal Diseases: Lyme Disease,Tick-Borne Rickettsial Diseases, Tularemia, Souther Tick-Associated Rash Illness, Babesiosis, Tick-Borne Relapsing Fever. A randomized trial of the acceptability of a daily multi-allergen food supplement for infants. Introduction. HIV Therapeutics - Antiretroviral Drugs and Immune-Based Therapies: HIV Reverse Transcriptase, HIV Reverse Transcriptase Inhibitors: Nucleoside Analogues, Nucleotide Analogues: Tenofovir DF, Reverse Transcriptase Inhibitors: Non-Nucleoside Analogues, HIV Protease, HIV Protease Inhibitors, Fixed-Dose Combinations, Viral Entry/Fusion Inhibitors, Integrase Inhibitors, Maturation Inhibitors, HAART: Triple Highly Active Antiretroviral Combinations.